Educational Program Through Video Conference for Inhaled Therapies in Cystic Fibrosis Patients

NCT03850145 | Completed

• 1 other identifier: RECHMPL19_0054
• Study Type: observational
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

Educational programs are essential for cystic fibrosis patients who need to take several different drugs every day. Compliance is often klow in these patients, and clinicals and paramedics try to increase it, through educational programs. As for inhaled therapies, the CF center of Montpellier uses a video conference tool to educate patients. The program may involve either the physiotherapist or the doctor or both. Through the present study, the investigators would like to evaluate the current practice at the CF center of Montpellier and verify if patients feel that the physiotherapist could handle the program on his own, without the support of a physician.

Conditions

Cystic Fibrosis

Keywords

inhaled therapy; physiotherapist; educational program

Outcome Measures

Primary Outcomes (2)

• acceptability of the therapeutic education program by videoconference

  acceptability of the therapeutic education program by videoconference with a satisfaction questionnaire

  1 day

• need for the presence of the referring physician in relation to a session of therapeutic education carried out by the physiotherapist alone

  need for the presence of the referring physician in relation to a session of therapeutic education carried out by the physiotherapist alone with a satisfaction questionnaire

  1 day

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

CF patients consulting at the CF center of Montpellier (France)

You may qualify if:

• CF patients
• patient regularly assessed at the CF center of Montpellier
• major patients
• patients who recently enrolled a video conference educational program or who will soon be part of it

You may not qualify if:

• patients not able to participate to a video conference educational program, due to lack of tools at their home

Sponsors & Collaborators

• University Hospital, Montpellier: lead

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Cystic Fibrosis

Condition Hierarchy (Ancestors)

Pancreatic Diseases; Digestive System Diseases; Lung Diseases; Respiratory Tract Diseases; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Infant, Newborn, Diseases

Study Officials

• Davide CAIMMI

  University Hospital, Montpellier

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 18, 2019
• First Posted: February 21, 2019
• Study Start: February 1, 2019
• Primary Completion: December 1, 2019
• Study Completion: December 30, 2019
• Last Updated: March 10, 2020

Record last verified: 2020-03

Locations

FR (1)